µ-Conotoxins as Leads in the Development of New Analgesics
AbstractVoltage-gated sodium channels (VGSCs) contain a specific binding site for a family of cone shell toxins known as µ-conotoxins. As some VGSCs are involved in pain perception and µ-conotoxins are able to block these channels, µ-conotoxins show considerable potential as analgesics. Recent studies have advanced our understanding of the three-dimensional structures and structure-function relationships of the µ-conotoxins, including their interaction with VGSCs. Truncated peptide analogues of the native toxins have been created in which secondary structure elements are stabilized by non-native linkers such as lactam bridges. Ultimately, it would be desirable to capture the favourable analgesic properties of the native toxins, in particular their potency and channel sub-type selectivity, in non-peptide mimetics. Such mimetics would constitute lead compounds in the development of new therapeutics for the treatment of pain.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Norton, R.S. µ-Conotoxins as Leads in the Development of New Analgesics. Molecules 2010, 15, 2825-2844.
Norton RS. µ-Conotoxins as Leads in the Development of New Analgesics. Molecules. 2010; 15(4):2825-2844.Chicago/Turabian Style
Norton, Raymond S. 2010. "µ-Conotoxins as Leads in the Development of New Analgesics." Molecules 15, no. 4: 2825-2844.